バイオテクノロジーの研究

Same author

Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.

International journal of clinical pharmacology and therapeutics·2009

Same author

Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral doses.

Methods and findings in experimental and clinical pharmacology·2008

Same author

Time course of chronic oral cadmium nephrotoxicity in Wistar rats: excretion of urinary enzymes.

Drug and chemical toxicology·1999

Same author

Prediction of stability in pharmaceutical preparations. XXI: The analysis and kinetics of hydrolysis of a cocaine degradation product, ecgonine methyl ester, plus the pharmacokinetics of cocaine in the dog.

Journal of pharmaceutical sciences·1994

Same author

Excretion of urinary enzymes in female Sprague-Dawley rats in relation to cellular compartment, creatinine excretion and diuresis.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1991

Same author

Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage.

Archives of toxicology·1990

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

関連する実験動画

バイオテクノロジーの研究

関連する概念動画

Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.

Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral doses.

Time course of chronic oral cadmium nephrotoxicity in Wistar rats: excretion of urinary enzymes.

Prediction of stability in pharmaceutical preparations. XXI: The analysis and kinetics of hydrolysis of a cocaine degradation product, ecgonine methyl ester, plus the pharmacokinetics of cocaine in the dog.

Excretion of urinary enzymes in female Sprague-Dawley rats in relation to cellular compartment, creatinine excretion and diuresis.

Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

関連する実験動画

バイオテクノロジーの研究

関連する概念動画

関連記事

Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.

Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral doses.

Time course of chronic oral cadmium nephrotoxicity in Wistar rats: excretion of urinary enzymes.

Prediction of stability in pharmaceutical preparations. XXI: The analysis and kinetics of hydrolysis of a cocaine degradation product, ecgonine methyl ester, plus the pharmacokinetics of cocaine in the dog.

Excretion of urinary enzymes in female Sprague-Dawley rats in relation to cellular compartment, creatinine excretion and diuresis.

Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.